RecruitingNCT02889016

Neurobiologic, Immunologic, and Rheumatologic Markers in Youth With PANS


Sponsor

Stanford University

Enrollment

500 participants

Start Date

Mar 1, 2013

Study Type

OBSERVATIONAL

Conditions

Summary

This study is an investigation of the neurologic, immunologic, and rheumatologic markers of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS). PANS is a condition characterized by the abrupt, dramatic onset of obsessive compulsive disorder (OCD) and/or eating restriction accompanied by equally abrupt and severe co-morbid neuropsychiatric symptoms, which include anxiety, emotional lability, depression, irritability, aggression, oppositionality, deterioration in school performance, behavioral (developmental) regression, sensory amplification, movement abnormalities, sleep disturbance, and urinary frequency. PANS is thought to be caused by infection, inflammation, or alternate triggers that is associated with a brain response that leads to these symptoms. The purpose of this study is to examine specific neurologic, immunologic, rheumatologic, and genomic, components in children with the acute-onset of psychiatric symptoms. This research may begin to uncover a much larger story of autoimmune processes that are involved in psychiatric disorders of childhood. By better understanding the etiologic components of psychiatric phenomenon, future treatments may be better targeted to underlying causes.


Eligibility

Min Age: 4 YearsMax Age: 18 Years

Inclusion Criteria8

  • Children with PANS
  • Age 1-18 at onset of PANS
  • Diagnosis of PANS: abrupt onset of OCD or food restriction, and at least two of the following associated symptoms: frequent urination, worsening handwriting/cognition, inattention, anorexia, separation anxiety, oppositionality, irritability/rage outbursts, and emotional lability.
  • Patients must live within 90 miles of Stanford University and have a new onset of PANS illness
  • Patients must have an established pediatrician within 90 miles of Stanford University for 3 years.
  • Healthy Controls
  • Age 4-18
  • No psychiatric diagnosis

Exclusion Criteria1

  • Any neuropsychiatric illness that may obscure the clear diagnosis of PANS

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Stanford University

Palo Alto, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02889016


Related Trials